Relevance tier by entity

Entity Tier Description
DLBCL 2 Role of TNF mutations in DLBCL requires confirmation

Mutation incidence in large patient cohorts (GAMBL reanalysis)

pathology Collection N mutated Incidence CI
BL GAMBL without Panea 309 0 0 [0,0]
BL GAMBL without ICGC/Zhou 320 0 0 [0,0]
BL GAMBL with Panea 410 0 0 [0,0]
BL BLGSP 219 0 0 [0,0]
BL Zhou/ICGC 90 0 0 [0,0]
BL Panea 101 0 0 [0,0]
Entity Collection N mutated Incidence 95% CI
DLBCL GAMBL without Reddy 1,089 23 0.0211 [0.0126,0.0297]
DLBCL GAMBL with Reddy 2,088 23 0.0110 [0.0065,0.0155]
DLBCL BC 231 3 0.0130 [0,0.0276]
DLBCL Dana-Farber 303 9 0.0297 [0.0106,0.0488]
DLBCL NCI 470 9 0.0191 [0.0068,0.0315]
DLBCL Reddy 999 0 0.0001 [0,7e-04]
DLBCL DLBCL_ICGC 85 2 0.0235 [0,0.0558]
pathology Collection N mutated Incidence CI
FL GAMBL with Crouch 1,189 1 0.0008 [-8e-04,0.0025]
FL BC 379 0 0.0003 [0,0.0019]
FL Kalmbach 164 0 0.0006 [0,0.0044]
FL Crouch 547 1 0.0018 [0,0.0054]
FL FL_ICGC 99 0 0.0010 [0,0.0073]

History

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% timeline title Publication timing 2012-03-06 : Lohr : DLBCL

References

1.
Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL, Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G, Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A, Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A, Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES, Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3879–3884. PMCID: PMC3309757